Emergent BioSolutions Inc. — Director's Dealing 2018

Nov 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-11-27

Reporting Person: Bailey Sue (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-27	Common Stock	M	8244	$18.64	Acquired	57216	Direct
2018-11-27	Common Stock	S	8244	$69.6197	Disposed	48972	Direct
2018-11-27	Common Stock	M	1579	$20.08	Acquired	50551	Direct
2018-11-27	Common Stock	S	1579	$69.6197	Disposed	48972	Direct
2018-11-27	Common Stock	M	4736	$13.00	Acquired	53708	Direct
2018-11-27	Common Stock	S	4736	$69.6197	Disposed	48972	Direct
2018-11-27	Common Stock	M	3158	$13.37	Acquired	52130	Direct
2018-11-27	Common Stock	S	3158	$69.6197	Disposed	48972	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-27	Stock Option (Right to buy)	$18.64	M	8244	Disposed	2021-05-21	Common Stock (8244)	Direct
2018-11-27	Stock Option (Right to buy)	$20.08	M	1579	Disposed	2021-05-18	Common Stock (1579)	Direct
2018-11-27	Stock Option (Right to buy)	$13.00	M	4736	Disposed	2020-05-22	Common Stock (4736)	Direct
2018-11-27	Stock Option (Right to buy)	$13.37	M	3158	Disposed	2019-05-16	Common Stock (3158)	Direct

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive.

F2: Consists of an option granted under the company's stock incentive plan as amended and restated.

F3: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.